Hepatitis B vaccine - Shanghai Fudan Haitai Biotechnology

Drug Profile

Hepatitis B vaccine - Shanghai Fudan Haitai Biotechnology

Alternative Names: HBsAg-HBIG complex; Hepatitis B immune globulin-hepatitis B vaccine recombinant complex; Hepatitis B vaccine/hepatitis B immune globulin; Yeast-derived immunogenic complex; YIC

Latest Information Update: 27 Nov 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fudan University
  • Developer Fudan University; Shanghai Haitai Pharmaceutical Biotechnology
  • Class Hepatitis B vaccines; Immunoglobulins; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Hepatitis B

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top